Dexfenfluramine enhances striatal dopamine release in conscious rats via a serotoninergic mechanism

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 3, 1998, Pages 991-997

  Balcioglu, Aygul ^a   Wurtman, Richard J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DEXFENFLURAMINE; DOPAMINE; METHIONINE; PHENTERMINE; SEROTONIN; SEROTONIN ANTAGONIST; SODIUM CHANNEL AFFECTING AGENT; TETRODOTOXIN;

ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC TRANSMISSION; SUBCUTANEOUS DRUG ADMINISTRATION; SUBSTANTIA NIGRA; WEIGHT REDUCTION;

ANIMALS; CORPUS STRIATUM; DOPAMINE; FENFLURAMINE; MALE; METHIOTHEPIN; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TETRODOTOXIN;

EID: 0031951628     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Benloucif S and Galloway MP (1991) Facilitation of dopamine release in vivo by serotonin agonists: Studies with microdialysis. Eur J Pharmacol 200:1-8.
2. Benloucif S, Keegan MJ and Galloway MP (1993) Serotonin-facilitated dopamine release in vivo: Pharmacological characterization. J Pharmacol Exp Ther 265:373-377.
3. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: A microdialysis study in the halothane-anesthetized rat. Neuropharmacology 34:269-279.
4. Carruba MO, Ricciardi S, Spano P and Mantegazza P (1985) Dopaminergic and serotoninergic anorectics differentially antagonize insulin-and 2-DG-induced hyperphagia. Life Sci 36:1739-1749.
5. 3 receptor activation in medial prefrontal cortex of freely moving rats. Synapse 10:264-266.
6. Christensen AV (1985) Classifications of neuroleptics: Implication for tardive dyskinesia. Pol J Pharmacol Pharm 37:295-309.
7. Costall B, Hui SCG and Naylor RJ (1979) The importance of serotonergic mechanisms for the induction of hyperactivity by amphetamine and its antagonism by intra-accumbens (3,4-dihydroxy-phenyl amine)-2-imidazoline (DPI), Neuropharmacology 18:605-609.
8. De Deurwaerdere P, Bonhomme N, Lucas G, Le Moal M and Spampinato U (1996) Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites. J Neurochem 66:210-215.
9. De Deurwaerdere P, Bonhomme N, Le Moal M and Spampinato U (1995) d-Fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites. J Neurochem 65:1100-1108.
10. Dringerberg HC and Vanderwolf H (1995) Some general anesthetics reduce serotonergic neocortical activation and enhance the action of serotonergic antagonists. Brain Res Bull 36:285-292.
11. Ferre S, Cortes R and Artigas F (1994) Dopaminergic regulation of the serotonergic raphe-striatal pathway: Microdialysis studies in freely moving rats. J Neurosci 14:4839-4846.
12. Galloway MP, Suchowski CS, Keegan MJ and Hjorth S (1993) Local infusion of the selective 5HT-1b agonist CP-93,129 facilitates striatal dopamine release in vivo. Synapse 15:90-92.
13. Garattini S, Bizzi A, Caccia S and Mennini T (1992) Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline. Int J Obes 16: suppl 3, S43-S50.
14. Garattini S, Borroni E, Mennini T and Samanin R (1978) Differences and similarities between anorectic agents, in Central Mechanisms of Anorectic Drugs (Garattini S and Samanin R, eds) pp 127-143, New York, Raven Press.
15. Garattini S, Mennini T and Samanin R (1987) From fenfluramine racemate to d-fenfluramine: Specificity and potency of the effects on the serotoninergic system and food intake. Ann NY Acad Sci 499:156-166.
16. Gardier AM, Kaakkola S, Erfurth A and Wurtman RJ (1992) Effects of methiothepin on changes in brain serotonin release induced by repeated administration of high doses of anorectic serotoninergic drugs. Brain Res 588:67-74.
17. Gardier AM, Trillat AC, Malagie I and Jacquot C (1994) 8-OH-DPAT attenuates dexfenfluramine-induced increase in extracellular serotonin: an in vivo dialysis study. Eur J Pharmacol 265:107-110.
18. Gardier AM and Wurtman RJ (1991) Persistent blockade of potassium-evoked serotonin release from rat frontocortical terminals after fluoxetine administration. Brain Res 540:325-330.
19. Giambalvo CT and Snodgrass ST (1978) Biochemical and behavioral effects of serotonin neurotoxins on the nigro-striatal dopamine system: Comparison of injection sites. Brain Res 152:555-556.
20. 3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes. Eur J Pharmacol 238:9-17.
21. Gobbi M, Miancini L, Presti ML and Mennini T (1996) Down-regulation of rat brain 5-HT uptake carriers after treatment with high doses of d-fenfluramine. Brain Res 730:165-172.
22. Gudelsky GA and Nash JF (1996) Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: Implications for serotonin-dopamine interactions. J Neurochem 66:243-249.
23. Hamilton ME, Mele A and Pert A (1992) Striatal extracellular dopamine in conscious vs. anesthetized rats: Effects of chloral hydrate anesthetic on responses to drugs of different classes. Brain Res 597:1-7.
24. Henderson MG, Perry KW and Fuller RW (1993) Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and β,β-difluoro-p-chloroamphetamine in rats. J Pharmacol Exp Ther 267:417-424.
25. Hernandez L, Lee F and Hoebel BG (1987) Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: Increase in extracellular dopamine and serotonin. Brain Res Bull 19:623-628.
26. 1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)-penbutolol. J Pharmacol Exp Ther 265:707-712.
27. Iyer RN and Bradberry CW (1996) Serotonin-mediated increase in prefrontal cortex dopamine release: Pharmacological characterization. J Pharmacol Exp Ther 277: 40-47.
28. Iyer RN, Sprouse JS, Aghajanian GK, Roth RH and Bradberry CW (1994) Tryptophan pretreatment augmentation of p-chloroamphetamine-induced serotonin and dopamine release and reduction of long-term neurotoxicity. Biochem Pharmacol 48:1501-1508.
29. Kametani H, Iijima S, Spangler EL, Ingram DK and Joseph JA (1995) In vivo assesment of striatal dopamine release in the aged male Fischer 344 rat. Neurobiol Aging 16:639-646.
30. Kuczenski R and Segal DS (1990) In vivo measures of monoamines during amphetamine-induced behaviors in rats. Prog Neuropsychopharmacol Biol Psychiatry 14: suppl, S37-S50.
31. Laferrere B and Wurtman RJ (1989) Effect of d-fenfluramine on serotonin release in brains of anaesthetized rats. Brain Res 504:258-263.
32. Marona-Lewicka D, Rhee GS, Sprague JE and Nichols DE (1995) Psychostimulant-like effects of p-fluoroamphetamine in the rat. Ear J Pharmacol 287:105-113.
33. McCann U (1994) Dexfenfluramine and serotonin neurotoxicity: Further preclinical evidence that clinical caution is indicated. J Pharmacol Exp Ther 269:792-798.
34. 3H-5-hydroxytryptamine. Pharmacol Biochem Behav 38:505-512.
35. i values. J Pharmacol Ther Exp 251:238-246.
36. Osborne NN, Neuhall V, Sontag KH and Wolfarth S (1978) A preliminary study on the behavior and biochemical responses subsequent to the injection of 5,6-dihydroxytryptamine into the substantia nigra of the rat. Experientia 34: 495-496.
37. Parsons LH and Justice JB Jr (1993) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in viuo microdialysis. Brain Res 606:195-199.
38. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. 2nd edition. Academic Press, Sydney.
39. Pettersson E (1995) Studies of four novel diphenylpiperazinepyridyl derivatives on release and inhibition of reuptake of dopamine, serotonin and noradrenaline by rat brain in vitro. Eur J Pharmacol 282:131-135.
40. Rose S, Hunt S, Collins P. Hindmarsh JG and Jenner P (1996) Repeated administration of escalating high doses of dexfenfluramine does not produce morphological evidence for neurotoxicity in the cortex of rats. Neurodegeneration 5:145-152.
41. Samanin R, Ghezzi D, Valzelli L and Garattini S (1972) The effects of selective lesioning of brain serotonin or catecholamine containing neurons on the anorectic activity of fenfluramine and amphetamine. Eur J Pharmacol 19:318-322.
42. Sarkissian CF, Wurtman RJ, Morse AN and Gleason R (1990) Effects of fluoxetine or d-fenfluramine on serotonin release from, and levels in, rat frontal cortex. Brain Res 529:294-301.
43. Schmidt CJ, Black CK and Taylor VL (1991) L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4 methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats. Eur J Pharmacol 203:41-49.
44. Soubrie P, Reisine TD and Glowinski J (1984) Functional aspects of serotonin transmission in the basal ganglia: A review and an in vivo approach using the push-pull cannula technique. Neuroscience 13:605-625.
45. Spedding M, Ouvry C, Millan M, Duhault J, Dacquet C and Wurtman R (1996) Neural control of dieting. Nature 380:488.
46. Steinbusch HW, van der Kooy D, Verhofstad AA and Pellegrino A (1980) Serotonergic and non-serotonergic projections from the nucleus raphe dorsalis to the caudate-putamen complex in the rat, studied by a combined immunofluorescence and fluorescent retrograde axonal labeling technique. Neurosci Lett 19:137-142.
47. Thurlby PL, Grimm VE and Samanin R (1983) Feeding and satiation observed in the runway: The effect of d-amphetamine and d-fenfluramine compared. Pharmacol Biochem Behav 18:841-846.
48. Tossman U and Ungerstedt U (1986) Microdialysis in the study of extracellular levels of amino acids in the rat brain. Acta Physiol Scand 128:9-14.
49. van Bockstaele EJ and Pickel VM (1993) Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: Cellular substrates for interactions with catecholamine afferents. J Comp Neurol 334:603-617.
50. van der Kooy D and Hattori T (1980) Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: A fluorescent retrograde double labeling study in the rat. Brain Res 186:1-7.
51. van der Moelen CP, Bonduki AC and Kitai ST (1979) Excitation of caudate putamen neurons following stimulation of the dorsal raphe nucleus in the rat. Brain Res 175:356-361.
52. West AR and Galloway MP (1996) Regulation of serotonin-facilitated dopamine release in vivo: The role of protein kinase A activating transduction mechanisms. Synapse 23:20-27.
53. Westerink BHC, Hofsteede RM, Tuntler J and Vries JB (1989) Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis. J Neurochem 52:722-729.
54. Westerink BHC, Tuntler G, Damsma G, Rollema H and de Vries JB (1987) The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain microdialysis. Naunyn-Schmiedeberg's Arch Pharmacol 336:502-507.
55. Wurtman RJ (1995) Brain serotonin, carbohydrate-craving, obesity and depression. Obes Res 3: suppl 4, 477S-480S.
56. Yadid G, Pacak K, Kopin IJ and Goldstein DS (1994) Endogenous serotonin stimulates striatal dopamine release in conscious rats. J Pharmacol Exp Ther 270:1158-1165.
57. Yamamoto M and Morayama S (1980) Effect of the serotonergic system on the caudate nucleus. Pharmacology 20:310-315.